H. Michael Shepard Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for H. Michael Shepard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of H. Michael Shepard. H. Michael Shepard is VP & Chief Scientific Officer in HALOZYME THERAPEUTICS INC ($GYHT) and VP, Chief Scientific Officer in HALOZYME THERAPEUTICS INC ($GYHT).
H. Michael Shepard in HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of H. Michael Shepard: VP & Chief Scientific Officer, VP, Chief Scientific Officer
Holdings: 13,198 shares
Latest Transaction: Sep 11 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of H. Michael Shepard in HALOZYME THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11 2013 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Sell | S | 7.11 | 10,000 | 71,091 | 13,198 | 23.2 K to 13.2 K (-43.11 %) |
| Feb 06 2013 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
| Feb 06 2013 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
| Feb 05 2013 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Buy | M | 0.00 | 3,508 | 0 | 23,198 | 19.7 K to 23.2 K (+17.82 %) |
| Feb 05 2013 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Buy | M | 0.00 | 8,290 | 0 | 19,690 | 11.4 K to 19.7 K (+72.72 %) |
| May 17 2012 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Buy | M | 0.00 | 11,400 | 0 | 11,400 | 0 to 11.4 K |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP & Chief Scientif ... | Option Exercise | A | 0.00 | 69,444 | 0 | 69,444 | |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP & Chief Scientif ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP & Chief Scientif ... | Option Exercise | A | 11.29 | 50,000 | 564,500 | 50,000 | |
| May 11 2011 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Feb 04 2011 | GYHT | HALOZYME THERAPEUT ... | Shepard H. Michael | VP, Chief Scientifi ... | Option Exercise | A | 7.14 | 40,000 | 285,600 | 40,000 |
Page: 1